Jul. 27 at 2:59 PM
Genvor, Inc. (OTCQB:
$GNVR ), a biotechnology company harnessing AI to generate novel peptides, said its proprietary antimicrobial peptides are being evaluated for their potential to address microbial challenges in sugar beet production, under the USDA Agricultural Research Service (ARS) Sustainable Sugar Beet Research Initiative.
Genvor is a @B2iDigital Featured Company. See the company's profile at https://b2idigital.com/genvor-incorporated-1
As a collaborator, the company is contributing its antimicrobial peptides for evaluation against key sugar beet microbial targets:
• USDA-ARS researchers will evaluate whether Genvor's antimicrobial peptides can inhibit key microbes involved in sugar beet root rot and in downstream sugar extraction
• The work may generate data to inform future peptide-based crop protection strategies
"Our work with collaborators has consistently demonstrated how much peptide science can contribute to agriculture," said Dr. Jesse Jaynes, Co-Founder of Genvor and the founding scientist behind the company's core peptide technologies. "Extending that collaboration into sugar beet lets us apply our peptides to a new set of microbial targets and continue advancing the design work that makes these tools more effective."
Read the full release: https://genvor.com/press-releases/post?storyId=6174274901791168
Genvor, Inc. (OTCQB: GNVR) is a biotechnology company harnessing AI to generate novel peptides that deliver high-performance solutions across agriculture and human health. Powered by its proprietary BioCypher platform and patented peptides, Genvor is developing and intends to commercialize biological actives for crop protection and plant health alongside consumer-focused peptide solutions for recovery, performance, anti-aging, and daily wellness. Learn more at https://www.genvor.com.
Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com.
Disclosure: David Shapiro, Chief Executive Officer of B2i Digital, personally purchased in the open market and currently owns shares of unrestricted GNVR stock, in line with B2i Digital's practice of investing alongside its Featured Companies. See the complete Disclosure at https://b2idigital.com/disclaimer. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security.
$EVGN $PTN $RKDA $DYAI